Adjuvant radiation therapy for high-grade and/or locally advanced major salivary gland tumors

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 10, 2011, Pages 1025-1030

  Mahmood, Usama ^a   Koshy, Matthew ^a   Goloubeva, Olga ^b   Suntharalingam, Mohan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PAROTID GLAND CANCER; REGRESSION ANALYSIS; SALIVARY GLAND TUMOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; FEMALE; HUMANS; MALE; NEOPLASM GRADING; RADIOTHERAPY, ADJUVANT; SALIVARY GLAND NEOPLASMS; SEER PROGRAM; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 80054762794     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.158     Document Type: Article

References (24)

1. Ward MJ, Levine PA. Salivary gland tumors. In: Close LG, Larson DL, Shah JP, eds. Essentials of Head and Neck Oncology. New York, NY: Thieme; 1998.
2. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8(3):177-184.
3. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumors: Pathology and Genetics of Head and Neck Tumours. 2nd ed. Lyon, France: IARC Press; 2005.
4. Greene FL, Page DL, Fleming ID, eds, et al. The American Joint Committee on Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
5. Therkildsen MH, Christensen M, Andersen LJ, Schiødt T, Hansen HS. Salivary gland carcinomas-prognostic factors. Acta Oncol. 1998;37(7-8):701-713.
6. Renehan AG, Gleave EN, Slevin NJ, McGurk M. Clinico-pathological and treatmentrelated factors influencing survival in parotid cancer. Br J Cancer. 1999;80 (8):1296-1300. (Pubitemid 29264095)
7. Pohar S, GayH,Rosenbaum P, et al. Malignant parotid tumors: presentation, clinical/ pathologic prognostic factors, and treatment outcomes. Int JRadiat Oncol Biol Phys. 2005;61(1):112-118. (Pubitemid 40039112)
8. Fu KK, Leibel SA, Levine ML, Friedlander LM, Boles R, Phillips TL. Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer. 1977;40(6):2882-2890.
9. Chen AM, Bucci MK,Weinberg V, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006;66(1):152-159. (Pubitemid 44175654)
10. Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnson JT, D'Amico F. Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy. Am J Otolaryngol. 1999;20(5):281-286. (Pubitemid 29437254)
11. Dai D. Postoperative irradiation in malignant tumors of submandibular gland. Cancer Invest. 1999;17(1):36-38. (Pubitemid 29072677)
12. Terhaard CH, Lubsen H, Rasch CR, et al. Dutch Head and Neck Oncology Cooperative Group. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 2005;61(1):103-111. (Pubitemid 40039111)
13. Frankenthaler RA, Luna MA, Lee SS, et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg. 1991;117(11):1251-1256.
14. Theriault C, Fitzpatrick PJ. Malignant parotid tumors: prognostic factors and optimum treatment. Am J Clin Oncol. 1986;9(6):510-516. (Pubitemid 17205981)
15. Bissett RJ, Fitzpatrick PJ. Malignant submandibular gland tumors: a review of 91 patients. Am J Clin Oncol. 1988;11(1):46-51. (Pubitemid 18061720)
16. Weber RS, Byers RM, Petit B, Wolf P, Ang K, Luna M. Submandibular gland tumors: adverse histologic factors and therapeutic implications. Arch Otolaryngol Head Neck Surg. 1990;116(9):1055-1060. (Pubitemid 20277077)
17. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin: a matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg. 1990;116(3):290-293. (Pubitemid 20100601)
18. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18(6):1319-1326. (Pubitemid 20234142)
19. Silverman DA, Carlson TP, Khuntia D, Bergstrom RT, Saxton J, Esclamado RM. Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck. Laryngoscope. 2004;114(7):1194-1199. (Pubitemid 38954572)
20. Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Int J Radiat Oncol Biol Phys. 2007;67(1):138-143. (Pubitemid 44959484)
21. Overview of the SEER program. Surveillance, Epidemiology, and End Results program Web site. http://seer.cancer.gov/about. Accessed January 1, 2010.
22. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program: SEER*Stat database: incidence-SEER 17 regs limited-use + Hurricane Katrina Louisiana impacted cases, Nov 2007 submission (1973-2005 varying)-linked to county attributes-total US, 1969-2005 counties. Bethesda, MD: National Cancer Institute; 2008. http://seer .cancer.gov/data/citation.html. Accessed January 1, 2008.
23. Bhattacharyya N, Fried MP. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol. 2005;26(1):39-44. (Pubitemid 40038074)
24. Lalami Y, Vereecken P, Dequanter D, Lothaire P, Awada A. Salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumors. Curr Opin Oncol. 2006;18(3):258-265. (Pubitemid 43740421)